Plasmid pCT is present in essentially all isolates of Chlamydia trachomatis and may encode factors important for survival in the natural environment. However, no pCT-associated phenotype has been described so far. With the purpose of investigating the possibility of a role of pCT in C. trachomatis pathogenicity, we examined the expression of an ORF (ORF3), potentially encoding a 28 kDa polypeptide (pgp3). Analysis of RNA extracted from chlamydia-infected Vero cells detected ORF3-specific transcripts, from 20 h post-infection onwards, mainly as discrete RNA species of 1390 nucleotides comprising the downstream ORF4 sequence. ORF3 DNA was cloned and expressed in Escherichia coli as a 39 kDa fusion protein (MS2/pgp3). Antibodies raised against purified MS2/pgp3, specifically recognized a 28 kDa protein on Western blots of protein from purified chlamydial elementary bodies (EBs). The same antibodies detected chlamydial inclusions in methanol-fixed infected cells by immunofluorescence. Western blot analysis of EBs extracted with 2 % Sarkosyl, showed that a large proportion of the 28 kDa antigen is associated with the detergent-insoluble (' membrane ') fraction. Antibodies recognizing pgp3 epitopes were detected in sera from patients with chlamydial infections, but not in sero-negative control sera. The findings support the hypothesis that pCT may provide a function related to chlamydial cell physiology.
Introduction
pCT is a plasmid of 7.5 kb described previously as pCHL1, pCTTl and pLGV440 (Palmer & Falkow, 1986; Sriprakash & MacAvoy, 1987; Hatt et al., 1988; Comanducci et al., 1988 Comanducci et al., , 1990b commonly found in all isolates of the human pathogen Chlamydia trachomatis, an obligate intracellular parasite of eukaryotic cells (Moulder et al., 1984; Moulder, 1985) . A recent report of a plasmid-less strain indicates that pCT may be nonessential for growth and propagation of C. trachomatis in tissue culture (Peterson et al., 1990) . However, in human infections there is clearly a strong selection in favour of this plasmid, since, except for the abovementioned case, it has been found in all serotypes and *Author for correspondence. Tel 577 293 239; fax 577 293 564; email RattiBirisOI . cineca. it.
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clinical isolates examined so far (Palmer & Falkow, 1986; Sriprakash & MacAvoy, 1987; Hatt et al., 1988; Comanducci et al., 1990b; Peterson et al., 1990) . Accordingly, studies in which the plasmid was used as a diagnostic target showed a good correlation between plasmid detection and tissue culture isolation (Horn et al., 1986; Dean et al., 1989; Ostergaard et al., 1990; Ratti et al., 1991) . No specific phenotype associated with pCT has been described so far; however, bacterial pathogenicity factors are often encoded on plasmids (Eberhard, 1989 ) and a similar situation could be true for C.
trachomatis.
Comparative sequence analysis of four pCT variants (Comanducci et al., 1990b) present in strains with different pathogenic properties (B and D serotypes, belonging to the 'trachoma' biovar, and Ll and L2 of the ' lymphogranuloma ' biovar) showed that the nucleotide sequence of pCT is strongly conserved, with < 1 % variation, and that a number of point mutations correlate with the biovar from which the plasmid is isolated. As a consequence, some of the polypeptides deducible from the eight major ORFs of pCT showed amino acid residues which are conserved in isolates of the same biovar, but differ between isolates belonging to different ' 1084
M . Comanducci and others
liovars. Interestingly, more than half of such biovarlinked substitutions (8/ 15) were found in the amino acid sequence specified by ORF3 (nomenclature according to Comanducci et al., 1990b) . The frequency of such mutations in ORF3 was significantly higher ( > sevenfold) when compared to the average value for all the other ORFs. Since this observation suggested a possible relationship between ORF3 and a chlamydial pathogenicity phenotype, we investigated the expression of this ]putative gene in the chlamydial cell.
In this paper we report on the detection and characterization of ORF3-specific transcripts in C. ,trachomatis and the identification of the ORF3-encoded ]product as a novel 28 kDa chlamydial antigen.
A preliminary report containing some data presented :in this paper has been published (Comanducci et al., 1990~) .
Methods
Bacterial strains and biological materials. Go/86 is a serotype D C. trachomatis strain, isolated in 1986 in Bologna, Italy, from a patient with non-gonococcal urethritis ; the serotype was confirmed by sequencing of the cloned ompl gene (M. Comanducci, unpublished data). The 7.5 kb plasmid cloned from Go/86 was described previously as a variant of pCHLl (Comanducci et al., 1990b) and here is more 'conveniently indicated as pCT-D. Chlamydia] infection of cultures of LLCMK2 (Rhesus monkey kidney), Vero or McCoy cells, and purification of elementary bodies (EBs) were performed by standard techniques (Caldwell et al., 1981) . pUC8-pCTD is a recombinant pUC8 plasmid (Vieira & Messing, 1982) , containing the whole pCT-D sequence as a BamHI insert (Comanducci et al., 1990b) . Plasmid expression vector pEX34A, a derivative of pEX29 and pEX31 (Strebel et al., 1986) , and host Escherichia coli K12 AHlAtrp (Remaut et al., 1983) were obtained from Dr R. Rappuoli (IRIS, Siena, Italy) and were originally gifts from Mo-Quen Klinkert (Centre for Molecular Biology, Heidelberg, Germany) and W. Fiers (State University of Ghent, Ghent, Belgium), respectively. The monoclonal antibody (mAb) specific for the N-terminal portion of bacteriophage MS2 replicase was a gift from Dr M. Bigio (IRIS, Siena, Italy). The anti-major outer-membrane protein (MOMP) mAb E7-12 has been described previously (Cevenini et af., 1987) . DNA techniques. Standard techniques were used throughout (Sambrook et al., 1989) . DNA sequencing (Sanger et af., 1977) was performed using the Sequenase kit (United States Biochemicals). Synthetic oligonucleotides were prepared with an automatic DNA synthesizer (Applied Biosystems, model 380B). Analysis of nucleotide and amino acid sequences was performed with the computer programs of the University of Wisconsin Genetics Computer Group (Devereux et al., 1984) .
Analysis of ORF3 transcripts. Chlamydia-infected LLCMK2 or Vero cells were grown in 150 cm2 flasks and after rinsing with PBS, directly solubilized in 10 ml of 4 M-guanidinium isothiocyanate, 25 mM-sodium (zitrate, pH 7.0, 0.5 YO Sarkosyl, and 0.1 M-2-mercaptoethanol. RNA (extraction, electrophoresis on formaldehyde-agarose (1.5 O h ) gels and Northern blots were performed as described by Chomczynski & Sacchi (1987) and Sambrook et af. (1989) . Probe A (Fig. l a ) was prepared from the ORF3 DNA segment described below for pEX34A cloning and was 32P-labelled by random priming (Sambrook et al., 1989) . Probe B (Fig. 1 a) was similarly prepared by PCR (Saiki et al., 1988 ) on the plasmid pUCg-pCTD, using the following primers : (49 18) 5' ATGCAAAATAAAAGAAAAG 3' (4936) and (5226) 5' CTATTC-AGCCTTGGAAAAC 3' (5208). The coordinates (indicated in parentheses) are expressed as the number of nucleotides from the unique BamHI site of pCT-D (Comanducci et al., 1990b) . Primer extensions on ORF3 and ORF4 transcripts were performed as described by Boorstein & Craig (1989) and Scarlato et al. (1989) , with primers (4136) 5' GGCTCTGTCATTTGCCCAAC 3' (41 17) and (5056) 5' GGTAGAG-TTCTAAGGGAGAA 3' (5037) for ORF3 and ORF4, respectively. The same primers were used for the sequencing reactions (Sanger et al., 1977) serving as size markers for fine mapping. S1-nuclease mapping experiments were performed as described by Berk (1 989). Probes C and D in Fig. l(a) were prepared by PCR followed by digestion with appropriate restriction endonucleases. For probe C, the primers C1 and C2 (Fig. 1 h) were used. The PCR product was digested with HindIII, to create a precise 5' end internal to the ORF sequence, electrophoretically purified and end-labelled with T4 polynucleotide kinase and [p3*P]ATP (Sambrook et al., 1989) . Probe C covered the DNA segment from the DdeI site at 113 bp upstream of the first ATG codon of ORF3 to the internal HindIII site (Fig. 1 b) . For probe D we used the primers D1 (Fig. Ib) , and D2: (5551) 5' GAATATCgAATTCTCTAAACTG 3' (the lower case letter indicates a mismatched nucleotide introduced to create an EcoRI site, underlined). The PCR product was digested with ClaI and EcoRI, purified and 3'-labelled with Klenow enzyme and [ N -~~P I~A T P (Sambrook et al., 1989) . Probe D corresponded to a 913 base DNA segment from 219 bp upstream from the stop codon of ORF3 to 226 bp inside the ORF5 sequence.
Cloning of ORF3. pUC8-pCTD (1 ng) was used as a template for PCR with the primers 3-1 and 3-2 (Fig. 16 ). Taq DNA polymerase and the GeneAmp kit (Perkin-Elmer Cetus) were used. Twenty-five PCR cycles (1 min at 94 "C, 1 min at 50 "C, 1 min at 72 "C) were performed. The amplified DNA fragment, cleaved with BamHI and PstI was purified by agarose gel electrophoresis and ligated to pEX34A. Competent cells of E. coli K12 AHlAtrp (Remaut et al., 1983) were transformed with the above ligation mixture, and grown at 30 "C in the presence of ampicillin (30 pg ml-*). One of the ampicillin-resistant (pEX34A phenotype) colonies was shown, by DNA sequencing, to contain a recombinant pEX34A plasmid with an in-frame DNA insert identical to ORF3 in pCT-D (Comanducci et al., 1990b) . This clone (E. coli P03/Go/MCl) was selected for further work.
Expression of ORF3 fusion gene in E. coli and purijication of the recombinant protein. The pEX34 expression vector/host system puts the cloned gene under the control of the A, , promoter of A bacteriophage and a ts mutant of its repressor, which is active at 30 "C but is inactivated at 42 "C. Exponential phase cultures of E. coli P03/Go/MCl were grown at 30 "C in LB medium containing 30 pg ampicillin ml-', and induced by a temperature shift to 42 "C. Urea (7 M) protein extracts of induced and non-induced cultures were prepared and analysed as described by Nicosia et al. (1987) . The 7 M-urea extracts were dialysed against PBS (10 mM-sodium phosphate, 15 mMNaCl, pH 7.4), at 4 "C overnight. This caused precipitation of several E. coli proteins, but left most of the MS2/pgp3 protein in solution. After dialysis, MS2/pgp3 was further purified by SDS-PAGE (Sambrook et al., 1989) . The protein eluted from the gels was precipitated with acetone (Harlow & Lane, 1988) , and resuspended in sterile PBS for antibody preparation. Protein concentrations were determined using the BCA Protein Assay Reagent (Pierce).
Preparation of anti-pgp3 antibodies. Three New Zealand White rabbits were injected in several lymph nodes with 20, 50 and 100 pg purified MS2/pgp3 protein (dissolved in 1 ml 0.15 M-NaCl and emulsified with 1 ml Freund's complete adjuvant), respectively. The same amounts were injected, together with Freund's incomplete 
3'
_-- adjuvant, 25, 40 and 55 days after the first injection. During the immunization, the increase in titre of anti-MS2/pgp3 antibodies was followed by Western blot analysis (Towbin et al., 1979 ) using a peroxidase-labelled mouse serum to rabbit immunoglobulins. The three sera, collected 15 days after the last injection, had similar titres (> 30000 in immunoblot assays) and were pooled for further use.
Immunojhorescence. Assays were performed as described by Cevenini er al. (1987) using monolayers of McCoy or LLCMK2 cell cultures (on glass coverslips). Thirty hours after infection with chlamydial EBs, cells were washed with sterile PBS and fixed with methanol at -20 "C. Incubations with anti-MS2/pgp3 rabbit serum (dilution 1 : 100-1 : 500 in PBS) were performed at room temperature for 30min, and were followed by incubation with fluorescein-labelled mouse serum to rabbit immunoglobulins (Boehringer). In some cases the cells were counterstained with Evans Blue. The inclusions were observed at 400 x and 
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@rimer 3-2) TGGAGTTTGTTTGCGAATgacgtcccc-5 ' . 1. Immunoblotting analyses. Electrophoresis of E. coli or C. trachomatis protein extracts was performed on SDS-polyacrylamide gels using the Laemmli system (Sambrook e f al., 1989) . Transfer onto nitrocellulose filters and immunodetection were performed as described previously (Cevenini et al., 1987 (Cevenini et al., , 1991 Towbin et al., 1979) . In the experiments with the anti-MS2/pgp3 rabbit serum the blots were developed with goat anti-rabbit IgGs conjugated with horseradish peroxidase (Cappel; dilution 1 : 2500), followed by colorimetric detection with 4-chloro-lnaphthol (Sambrook et al., 1989) . Analysis with human sera was performed with 32 sera containing antibodies against C. tvachomatis (obtained from patients referred to the Microbiology Institute, St Orsola Hospital, Bologna, Italy, for diagnosis of chlamydial infection) and 20 control sera from sero-negative healthy blood donors. Anti- antibody complexes were detected with a peroxidase-labelled rabbit antiserum to human immunoglobulin (Dako) as described previously (Cevenini et al., 1991) .
Detergent treatments. Samples of purified EBs, containing about 1 mg protein in 1 ml PBS, were centrifuged in an Eppendorf centrifuge at 14000 r.p.m. at 4 "C. The EB pellets were resuspended twice in PBS containing 1 % (w/v) disodium N-lauryl-sarkosine (Sarkosyl), briefly sonicated, incubated for 1 h at 37 "C and centrifuged at 1OOOOOg for 1 h. The insoluble pellets so obtained were then resuspended in (i) 2 YO Sarkosyl in PBS, (ii) 2 % Sarkosyl in PBS with 10 mM-DTT, (iii) 2 YO (w/v) SDS in PBS, or (iv) 2% SDS in PBS with 10 m~-D T T . These suspensions were incubated for 1 h at 37 "C and again centrifuged at 100000 g. Supernatants and pellets were collected and analysed by Western blotting.
Protease treatments. Samples of purified EBs corresponding to about 150 pg protein were pelleted and resuspended in 1 ml 0.25 Msucrose-10 mM-sodium phosphate-5 mM-L-glutamic acid (PH 7.2) containing either 50 pg trypsin (Type XIII, Sigma), chymotrypsin A4 (Sigma) or thermolysin (Boehringer, Mannheim, Germany) m1-l. These suspensions were incubated for 2 h at 37 "C in a shaking water bath. PMSF (Boehringer) was then added and the samples were chilled at 4 "C. After centrifugation, the pellets were dissolved in Laemmli's sample buffer and aliquots were analysed by Western blotting.
Results
ORF3 transcripts
RNA transcripts from the ORF3 region of pCT (Fig. 1) were analysed on Northern blots of RNA extracted from Vero cells before infection and at 6, 17, 20, 30 and 48 h post-infection ( p i ) with C. trachomatis. Fig. 2 (a) shows a blot hybridized with probe A (Fig. 1 a) , corresponding to the whole ORF3 (792 bp). A major RNA band, with a mobility corresponding to about 1300 nucleotides (nt), was detected in the 20, 30 and 48 h samples, whereas no bands were detectable in the earlier samples up to 17 h p.i. Two minor bands of about 1000 and 800 nt were also detected. The intensity of the signals increased at 30 h and decreased in the 48 h sample, when loss of intracellular chlamydiae, due to host-cell lysis, started to occur. ORF3 transcripts were further analysed by S1-mapping and primer extension experiments, performed on the RNA sample collected 30 h p i , and using the preinfection sample as a control. S1-nuclease protection assays ( Fig. 3a) with probe C (see Fig. 1 a) showed that a major RNA species in the 30 h sample had a 5' end mapping at about 19 nt from the ATG start codon of ORF3. This result was confirmed by primer extension analysis (not shown) with an oligonucleotide complementary to the 5'-terminal region of ORF3 mRNA (see Fig. lb) . We concluded that the major 1300 nt band detected on Northern blots by probe A represents a transcript starting immediately upstream of ORF3. In this case, the transcript would extend for > 500 nt after the stop codon of ORF3, including therefore the whole ORF4 sequence. This hypothesis was investigated by Northern blot analysis with probe B (Fig. la) , corresponding to ORF4. This probe detected a 1300 nt band, as with probe A, and two other bands at about 500 and 330 nt (Fig. 2b) . Interestingly, the 1000 and 800 nt bands hybridizing to probe A were not detected by probe B.
Further data were obtained by S 1 -nuclease protection experiments designed to map RNA 3' ends in the region between 600 and 1500 nt from the start of ORF3 (probe Lanes: 1 and 6, molecular mass markers; 2 and 3, control samples containing no RNA before (2) and after (3) S1-nuclease treatment; 4 and 5, results obtained with RNA from Vero cells before (4) and 30 h after chlamydial infection (5). The major S 1-nuclease-protected segment in lane 5, given by transcripts starting upstream, and ending within the probe D sequence (see Fig. 1 a) , is indicated as T3,4. D, Fig. la) . The probe was 3'-end-labelled with 32P, hybridized to the same 30 h p.i. RNA sample used previously, and digested with S 1 -nuclease. The results (Fig. 3c) showed a major protected DNA band of about 800 bases, which corresponded to an RNA transcript originating upstream of probe D, and ending about 113 nt within the ORF5 sequence (Fig. 1 a) . Therefore both 5' and 3' end mapping data are consistent with the presence of a 1390 nt long ORF3-ORF4 transcript, in good agreement with the 1300 nt value deduced from Northern blot analysis.
Since Northern blot analysis indicated the presence of RNA species hybridizing to ORF4 probes but not to ORF3 probes, a primer complementary to a sequence downstream of the ATG start codon of ORF4 was hybridized to chlamydial mRNA and extended to detect possible RNA 5' ends immediately upstream of ORF4. The result (Fig. 3b) showed the presence of an RNA 5' end mapping at 29 nt upstream of the ATG start codon of ORF4. A transcript starting at this site and ending at the major RNA 3' endpoint would be 539nt long, a value which is consistent with the presence of the band at 500nt on the Northern blots. The minor RNA bands seen on Northern blots, and minor S 1-nuclease-protected DNA bands observed in the 3' end mapping experiment, could be due to RNA degradation or processing; these molecular species, being outside the scope of the present study, were not investigated further.
The ORF3-encoded protein
The segment of pCT-D DNA corresponding to ORF3 (Fig. 1 b) was cloned into the inducible expression vector pEX34A. E. coli cells, transformed with the recombinant vector, overexpressed, on induction, a 39 kDa hybrid protein (MS2/pgp3) which, according to the DNA construct, should comprise an 11 kDa N-terminal segment of the MS2 bacteriophage replicase fused to the uble) fractions. Sarkosyl-soluble and -insoluble fractions were analysed by Western blotting, using a mixture of anti-pgp3 rabbit serum and, as a control, a mAb against the MOMP. The results showed that, whilst some of the 28 kDa antigen was solubilized by 2 % Sarkosyl, a greater proportion of it remained associated with the insoluble, 'membrane' fraction (Fig. 6) . The control treatments with 2 YO SDS, in contrast, solubilized most of the MOMP and all of the 28 kDa antigen. The behaviour of the 28 kDa antigen essentially paralleled that observed for the MOMP, with the exception that Sarkosyl treatment under reducing conditions, which did not alter MOMP solubility, appeared to release a certain amount of the 28 kDa antigen into the supernatant (Fig. 6, lanes  6 and 7) . To investigate whether parts of the 28 kDa antigen could be exposed on the chlamydial surface, purified EB samples were treated with proteases (achymotrypsin, thermolysin and trypsin) and analysed by immunoblotting. Protease-digested EB protein extracts were analysed by Western blotting. The results (Fig. 7) showed that, whilst the surface-exposed MOMP was sensitive to protease digestion as expected (Hackstadt & Caldwell, 1985) , the 28 kDa band was not affected. Fig. 4 . Detection of the 28 kDa chlamydial antigen by antibodies raised against the 39 kDa pgp3 fusion protein. Protein samples were dectrophoretically fractionated on 12.5 YO SDS-polyacrylamide gels, blotted on nitrocellulose and reacted with the rabbit serum described in the text. Lane 1 : partially purified protein extract (Nicosia et al., 1987) of E. coli over-expressing the 39 kDa fusion protein; the equivalent of 40 pl of an overnight culture was loaded on the gel. Lane 2: purified G0/86 EBs (equivalent of 50 pg of EB protein) were solubilized by boiling in Laemmli's sample buffer, containing 1 YO SDS, 10 m~-2 -mercaptoethanol, and loaded directly on the gel.
:28 kDa chlamydial polypeptide, pgp3 (Fig. 1 b) . Rabbits 'were immunized with electrophoretically purified MS2/ :pgp3 and the serum so obtained was used to detect the .putative ORF3 product in the chlamydial cell. Fig. 4 ;shows an immunoblot analysis of partially purified E. ,coZi extracts containing MS2/pgp3 (lane l), and protein extracted from purified EBs of C . trachomatis Go/86 (lane 2). The serum recognizes the 39 kDa band used for immunization in the E. coli extract (smaller additional bands are possibly degradation products), and only one protein band, of 28 kDa in the chlamydial extract. Similar blots (not shown) developed with a mAb specific for the MS2-replicase segment, showed the 39 kDa band in the E. coli extract but no bands in the chlamydial extract. The rabbit serum could specifically detect, by indirect immunofluorescence, typical chlamydial inclusions in infected cell cultures, which were fixed with methanol 30 h p i . (Fig. 5) . The fluorescence within the chlamydial inclusions appeared both as a diffused cloud and as discrete, more brilliant dots of variable size. Attempts to detect a reaction of the anti-MS2/pgp3 serum with unfixed EB preparations by immunofluorescence gave negative results.
Membrane association of the 28 kDa antigen
Purified EBs were treated with 2 YO Sarkosyl or 2 O/ O SDS in the presence or absence of a reducing agent (Bavoil et al., 1984) . Sarkosyl treatment is commonly assumed to discriminate the proteins of Gram-negative bacteria into ' outer-membrane ' (insoluble) and ' cytoplasmic ' (sol-
Recognition of pgp3 by human immune sera
The possibility that antigenic determinants of pgp3 may be immunogenic in human chlamydial infections was investigated by immunoblot analysis with sera from 32 patients positive for anti-chlamydia antibodies, and 20 sero-negative blood donor controls. The patient sera were obtained either from females with pelvic inflammatory disease (PID; 10 cases) or from males with isolation-positive chlamydial urethritis (22 cases). The group selected had anti-chlamydia IgG titres of 2 64 (male urethritis cases) or 128-520 (PID cases). Screening with chlamydial EB extracts was found to be unsuitable because for immunoblot detection of bands in the 28 kDa range, the SDS-polyacrylamide gels had to be overloaded with a consequent loss of resolution. Furthermore, other chlamydial antigens in the 27-29 kDa range have been described and assignment of signals to the plasmid-encoded 28 kDa antigen would have been unreliable. Analysis was therefore performed with a partially purified protein extract from E. coli overexpressing the MS2/pgp3 protein. Controls were performed with similar extracts from E. coli transformed with the pEX34A vector, and therefore overexpressing the MS2-replicase peptide only. All sera were used at a standard 1 : 100 dilution, and none of them reacted with the MS2 peptide encoded by the pEX34A vector, All 20 chlamydia-negative control sera reacted with one or more bands of the E. coZi extracts, but none of them reacted with the recombinant 39 kDa antigen. A typical Plasmid-encoded 28 kDa antigen of C. trachomatis 1089 result is shown in Fig. 8 , strip 1. In contrast 15 (68 YO) of the 22 urethritis sera, and all the PID sera showed, besides the variable pattern of E. coli bands observed in the control sera, a clear reaction with the MS2/pgp3 protein band. In Fig. 8 , strips 2-16, typical immunoblots obtained from patients from both patient groups are shown. It can be seen that the intensity of signal from the overexpressed MS2/pgp3 antigen was variable, but did not seem to correlate with the general intensity of response to E. coli antigens.
Discussion
ORF3 transcripts were detected in the late phase of the chlamydia1 infection cycle mostly as dicistronic RNA molecules together with ORF4; however, transcripts of ORF3 or ORF4 alone were also detected. Two RNA 5' ends were mapped at 19 and 29 nt upstream from the ATG start codons of ORF3 and ORF4, respectively, and a single major RNA 3' end was mapped at 1390 and 536nt from the two 5' ends, respectively. No transcription termination signals could be identified near the 3' end map positions from nucleotide sequence analysis.
Sequences at 10 and 35 nt upstream of the startpoint of ORF3 transcripts (Fig. 1 b) , TTTAAA and TTGAAA, respectively, show similarity to the -10 (TATAAT) and -35 (TTGACA) consensus sequences for selected promoters in E. coli. The chlamydial -35 sequence T . .C. . . .CTTGA may also be considered as similar to -35 sequences found in selected heat-shock promoters of E. coli (TNtCNCcCTTGAA; Cowing et al., 1985) . A putative chlamydial promoter with similar characteristics (i.e. similarity to E. coli heat-shock promoters limited to the -35 region only) has been described for a gene encoding a chlamydial protein homologous to the heat-shock DnaK protein of E. coli. However, whilst the putative dnaK promoter (Birkelund et al., 1990 ) and other pCT promoters (Ricci et al., 1993) have been reported to function in E. coli, attempts to detect ORF3 transcripts in pCT-transformed E. coli (grown at 27, 37 or 42 "C) gave negative results (unpublished data). Similarly, we could not identify promoter sequences for ORF4 or detect ORF4 transcription in E. coli (unpublished data). Therefore, whether ORF3-0RF4 transcription in C. trachomatis is controlled by sequences immediately upstream of these ORFs remains to be proven.
ORF3 was expressed in E. coli as a 39 kDa fusion protein. Antibodies against this protein were monospecific for a 28 kDa antigen present in protein extracts of chlamydial EBs and recognized chlamydial inclusions in methanol-fixed infected cell cultures. These data suggest that the 28 kDa chlamydial antigen is probably identical to the ORF3-encoded polypeptide, pgp3. Furthermore, the isoelectric point of the 28 kDa EB antigen deducible from bidimensional electrophoretic maps (PI = 4-3-46; L. Bini & V. Pallini, personal communication) is in agreement with the value which can be calculated for the pgp3 amino acid sequence.
The 28 kDa antigen remained essentially insoluble upon treatment with Sarkosyl, a property which is typical of outer-membrane proteins in Gram-negative bacteria. Although C. trachomatis is an atypical Gramnegative bacterium lacking peptidoglycan, treatment of EBs with Sarkosyl was shown to generate cytoplasmdeprived cell 'ghosts' (Caldwell et al., 1981) called chlamydial outer-membrane complexes (COMCs). This solubility behaviour would not have been predicted from the amino acid sequence of pgp3, since it does not show a recognizable N-terminal signal peptide for secretion, nor a hydrophobicity profile (Devereux et al., 1984; Kyte & Doolittle, 1982) indicative of a membrane protein. Also, the stability of the 28 kDa protein towards protease digestion of intact EBs, and the fact that for immunofluorescence detection, methanol fixation of the inclusions was required for antibody accessibility, argue against a surface location of this antigen. Therefore, Sarkosyl insolubility seems more likely to be due to some kind of interaction of the 28 kDa protein with membrane structures, e.g. through a specific domain or a side-chain modification providing a membrane-anchoring moiety. Alternatively, the protein could be transported into the periplasmic space by a secretion system not requiring a classical N-terminal signal peptide, and could remain in this way entrapped in the Sarkosyl-insoluble COMCs. Specific IgG's present in the sera of some patients, with proven or probable C. trachomatis infection, recognized ORF3-encoded peptides. The implication is that these antibodies may be generated by an immune response elicited by the plasmid-encoded 28 kDa antigen in the course of chlamydial infections. This observation adds interest for further investigations on the significance of this new antigen for chlamydial pathogenicity. On the whole, the data support the initial hypothesis (Comanducci et al., 1990b ) that plasmid gene ORF3 has some function in the chlamydial cell rather than being required just for plasmid maintenance.
